HC Wainwright Issues Pessimistic Forecast for Galiano Gold (NYSEAMERICAN:GAU) Stock Price
Galiano Gold (NYSEAMERICAN:GAU – Get Free Report) had its target price dropped by stock analysts at HC Wainwright from $3.10 to $2.80 in a research note issued on Wednesday,Benzinga reports. The firm ...
FY2024 Earnings Estimate for uniQure Issued By HC Wainwright
HC Wainwright decreased their FY2024 earnings per share estimates for uniQure in a report released on Monday, January 27th. HC Wainwright analyst P. Trucchio now anticipates that the biotechnology ...
Hosted on MSN13h
HC Wainwright & Co. Initiates Coverage of Knightscope (KSCP) with Buy Recommendation
Fintel reports that on January 30, 2025, HC Wainwright & Co. initiated coverage of Knightscope (NasdaqCM:KSCP) with a Buy ...
H.C. Wainwright Remains a Buy on Neptune Digital Assets (NDA)
In a report released today, Kevin Dede from H.C. Wainwright maintained a Buy rating on Neptune Digital Assets (NDA – Research Report), with a ...
Fintel on MSN19h
HC Wainwright & Co. Initiates Coverage of Surrozen (SRZN) with Buy Recommendation
Fintel reports that on January 30, 2025, HC Wainwright & Co. initiated coverage of Surrozen (NasdaqCM:SRZN) with a Buy ...
H.C. Wainwright Remains a Buy on Bioxcel Therapeutics (BTAI)
H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Bioxcel Therapeutics (BTAI – Research Report) yesterday and set a price target ...
Investing14d
H.C. Wainwright sets target on Aprea stock, Buy rating on clinical update
On Thursday, H.C. Wainwright reaffirmed its Buy rating and $20.00 stock price target for Aprea Therapeutics (NASDAQ:APRE), a biopharmaceutical company focused on developing and commercializing novel ...
Investing15d
H.C. Wainwright reiterates TG Therapeutics stock buy rating on growth
On Wednesday, H.C. Wainwright reaffirmed a Buy rating on shares of TG Therapeutics (NASDAQ:TGTX) shares with a steady price target of $55.00. The firm's analyst highlighted the company's strong ...